Outcomes of patients with infection related to a ventricular assist device after heart transplantation

Despite significant advances in durable mechanical support survival, infectious complications remain the most common adverse event after ventricular assist device (VAD) implantation and the leading cause of early death after transplantation. In this study, we aim to describe our local infectious epidemiology and review short‐term survival and infectious incidence rates in the post‐transplantation period and assess risk factors for infectious episodes after transplantation.

[1]  Amir Ali Sepehry,et al.  The Impact of Left Ventricular Assist Device Infections on Postcardiac Transplant Outcomes: A Systematic Review and Meta-Analysis. , 2019, ASAIO journal.

[2]  M. Hannan,et al.  Epidemiology, Outcomes, and Effects of Device Flow Type on Ventricular Assist Devices (VAD) Infections: An IMACS Registry Analysis , 2019, The Journal of Heart and Lung Transplantation.

[3]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  H. Katus,et al.  COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival , 2018, Clinical epidemiology.

[5]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  Takeshi Nakatani,et al.  Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  D. Chahal,et al.  (78) - The Impact of LVAD Related Infections on Post Cardiac Transplant Outcomes: A Systematic Review , 2017 .

[8]  F. Ruschitzka,et al.  Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections , 2016, BMC Infectious Diseases.

[9]  N. Smedira,et al.  Outcomes of Heart Transplant After Left Ventricular Assist Device Specific and Related Infection. , 2015, The Annals of thoracic surgery.

[10]  M. Barten,et al.  Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression , 2014, Transplant international : official journal of the European Society for Organ Transplantation.

[11]  G. Ewald,et al.  Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  Francis D. Pagani,et al.  Prospective, Multicenter Study of Ventricular Assist Device Infections , 2013, Circulation.

[13]  V. Topkara,et al.  Left ventricular assist device-related infections: past, present and future , 2011, Expert review of medical devices.

[14]  M. Hannan,et al.  Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  Clive Lewis,et al.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  S. Russell,et al.  Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. , 2010, The Journal of thoracic and cardiovascular surgery.

[17]  Allison R. Schulman,et al.  Effect of left ventricular assist device infection on post-transplant outcomes. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.